In our previous work, the compound halofuginone (HF) was shown to potentiate its bioactivity to inhibit Akt/mTORC1 and retard tumor growth under nutrient-rich condition.15 Notably, inhibition of mTORC1 may induce autophagy by phosphorylating ULK1. The gene discussed is AKT1; the disease is neoplasm.